Maintenance immunosuppression regimens: Conversion, minimization, withdrawal, and avoidance

American Journal of Kidney Diseases

Volumn 47, Issue 4 SUPPL. 2, 2006, Pages

  Yang, Harold ^a  

^a Pinnacle Health System   (United States)

Author keywords

Calcineurin inhibitor (CNI) minimization; Conversion; Corticosteroid withdrawal; Cyclosporine (CsA); Mycophenolate mofetil (MMF); Sirolimus (SRL); Tacrolimus (TAC)

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLACEBO; RAPAMYCIN; TSUKUBAENOLIDE;

CARDIOVASCULAR RISK; CLINICAL TRIAL; DRUG WITHDRAWAL; GASTROINTESTINAL SYMPTOM; GLUCOSE INTOLERANCE; HEART DEATH; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LONG TERM CARE; NEPHROTOXICITY; PHYSICAL DISEASE; REVIEW; TREMOR;

EID: 33645287686     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2005.12.045     Document Type: Article

References (112)

1. P.J. Morris Transplantation - A medical miracle of the 20th century N Engl J Med 351 2004 2678 2680
2. M.P. Curran, G.M. Keating Mycophenolate sodium delayed release Prevention of renal transplant rejection Drugs 65 2005 799 805
3. R. Shapiro, J.B. Young, E.L. Milford, J.F. Trotter, R.T. Bustami, A.B. Leichtman Immunosuppression Evolution in practice and trends, 1993-2003 Am J Transplant 5 2005 874 886
4. H.-U. Meier-Kriesche, J.D. Schold, T.R. Srinivas, B. Kaplan Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era Am J Transplant 4 2004 378 383
5. S. Hariharan, C.P. Johnson, B.A. Bresnahan, S.E. Taranto, M.J. McIntosh, D. Stablein Improved graft survival after renal transplantation in the United States, 1988 to 1996 N Engl J Med 342 2000 605 612
6. H.-U. Meier-Kriesche, J.D. Schold, B. Kaplan Long-term renal allograft survival Have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant 4 2004 1289 1295
7. M. Pascual, T. Theruvath, T. Kawai, N. Tolkoff-Rubin, A.B. Cosimi Strategies to improve long-term outcomes after renal transplantation N Engl J Med 346 2002 580 590
8. H.A. Kreis, C. Ponticelli Causes of late renal allograft loss Chronic allograft dysfunction, death, and other factors Transplantation 71 suppl 11 2001 S5 S9
9. K.L. Womer, J.P. Vella, M.H. Sayegh Chronic allograft dysfunction Mechanisms and new approaches to therapy Semin Nephrol 20 2000 126 147
10. B. Fellström Nonimmune risk factors for chronic renal allograft dysfunction Transplantation 71 suppl 11 2001 S10 S16
11. S. Hariharan, M.A. McBride, W.S. Cherikh, C.B. Tolleris, B.A. Bresnahan, C.P. Johnson Post-transplant renal function in the first year predicts long-term kidney transplant survival Kidney Int 62 2002 311 318
12. K.M. Wissing, D. Abramowicz, N. Broeders, P. Vereerstraeten Hypercholesterolemia is associated with increased kidney graft loss caused by chronic rejection in male patients with previous acute rejection Transplantation 70 2000 464 472
13. J.D. Pirsch, J. Miller, M.H. Deierhoi, F. Vincenti, R.S. Filo FK506 Kidney Transplant Study Group A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation Transplantation 63 1997 977 983
14. A.D. Mayer, J. Dmitrewski, J.-P. Squifflet Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection A report of the European Tacrolimus Multicenter Renal Study Group Transplantation 64 1997 436 443
15. J. Grinyo, C. Groth, R. Pichlmayr Placebo-controlled study of mycophenolate mofetil combined with cyclosporine and corticosteroids for prevention of acute rejection Lancet 345 1995 1321 1325
16. H.W. Sollinger US Renal Transplant Mycophenolate Mofetil Study Group Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients Transplantation 60 1995 225 232
17. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation Transplantation 61 1996 1029 1037
18. P. Halloran, T. Mathew, S. Tomlanovich, C. Groth, L. Hooftman, C. Barker International Mycophenolate Mofetil Renal Transplant Study Group Mycophenolate mofetil in renal allograft recipients A pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection Transplantation 63 1997 39 47
19. B.D. Kahan Rapamune Study Group Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection A randomised multicentre study Lancet 356 2000 194 202
20. A.S. MacDonald Rapamune Global Study Group A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts Transplantation 71 2001 271 280
21. A.O. Ojo, H.-U. Meier-Kriesche, J.A. Hanson Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection Transplantation 69 2000 2405 2409
22. C. Johnson, N. Ahsan, T. Gonwa Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation Transplantation 69 2000 834 841
23. R. Margreiter European Tacrolimus vs Ciclosporin Microemulsion Renal Transplantation Study Group Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation A randomized multicentre study Lancet 359 2002 741 746
24. G. Ciancio, G.W. Burke, J.J. Gaynor A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (Neoral) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year Transplantation 77 2004 244 251
25. T. Gonwa, C. Johnson, N. Ahsan Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation Results at three years Transplantation 75 2003 2048 2053
26. W.A. Jurewicz Tacrolimus versus ciclosporin immunosuppression Long-term outcome in renal transplantation Nephrol Dial Transplant 81 suppl 1 2003 Si7 Si11
27. K.L. Hardinger, D.L. Bohl, M.A. Schnitzler, M. Lockwood, G.A. Storch, D.C. Brennan A randomized, prospective, pharmacoeconomic trial of tacrolimus versus cyclosporine in combination with thymoglobulin in renal transplant recipients Transplantation 80 2005 41 46
28. T. Gonwa, R. Mendez, H.C. Yang Prograf Study Group Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation Results at 6 months Transplantation 75 2003 1213 1220
29. G. Ciancio, G.W. Burke, J.J. Gaynor A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (Neoral)/sirolimus in renal transplantation. II. Survival, function, and protocol compliance at 1 year Transplantation 77 2004 252 258
30. J.P. van Hoof, J.-P. Squifflet, Z. Wlodarczyk, Y. Vanrenterghem, L. Paczek A prospective randomized multicenter study of tacrolimus in combination with sirolimus in renal-transplant recipients Transplantation 75 2003 1934 1939
31. J.M.M. Boots, M.H.L. Christiaans, J.P. van Hooff Effect of immunosuppressive agents on long-term survival of renal transplant recipients Focus on the cardiovascular risk Drugs 64 2004 2047 2073
32. S.C. Jensik FK506 Kidney Transplant Study Group Tacrolimus (FK506) in kidney transplantation Three-year survival results of the US multicenter, randomized, comparative trial Transplant Proc 30 1998 1216 1218
33. F. Vincenti, S.C. Jensik, R.S. Filo, J. Miller, J. Pirsch A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation Evidence for improved allograft survival at five years Transplantation 73 2002 775 782
34. I.H.H.T. Klein, A. Abrahams, T. van Ede, R.J. Hené, H.A. Koomans, G. Ligtenberg Different effects of tacrolimus and cyclosporine on renal hemodynamics and blood pressure in healthy subjects Transplantation 73 2002 732 736
35. F.G. Cosio, Y. Kudva, M. van der Velde New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation Kidney Int 67 2005 2415 2421
36. L.A. Bäckman Post-transplant diabetes mellitus The last 10 years with tacrolimus Nephrol Dial Transplant 19 suppl 6 2004 Svi13 Svi16
37. M.R. First Improving long-term renal transplant outcomes with tacrolimus Speculation vs evidence Nephrol Dial Transplant 19 suppl 6 2004 Svi17 Svi22
38. A. Teutonico, P.F. Schena, S. Di Paolo Glucose metabolism in renal transplant recipients Effect of calcineurin inhibitor withdrawal and conversion to tacrolimus J Am Soc Nephrol 16 2005 3128 3135
39. H.-U. Meier-Kriesche, B.J. Steffen, A.M. Hochberg Mycophenolate mofetil versus azathioprine therapy is associated with a significant protection against long-term renal allograft function deterioration Transplantation 75 2003 1341 1346
40. A.O. Ojo, P.J. Held, F.K. Port Chronic renal failure after transplantation of a nonrenal organ N Engl J Med 349 2003 931 940
41. H.-U. Meier-Kriesche, B.J. Steffen, A.H. Chu Sirolimus with Neoral versus mycophenolate mofetil with Neoral is associated with decreased renal allograft survival Am J Transplant 4 2004 2058 2066
42. T.A. Gonwa, D.E. Hricik, K. Brinker, J.M. Grinyo, F.P. Schena Sirolimus Renal Function Study Group Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination Transplantation 74 2002 1560 1567
43. M.A. Artz, J.M.M. Boots, G. Ligtenberg Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile Am J Transplant 4 2004 937 945
44. G. Ligtenberg, R.J. Hené, P.J. Blankestijn, H.A. Koomans Cardiovascular risk factors in renal transplant patients Cyclosporin A versus tacrolimus J Am Soc Nephrol 12 2001 368 373
45. S. Baid-Agrawal, F.L. Delmonico, N.E. Tolkoff-Rubin Cardiovascular risk profile after conversion from cyclosporine A to tacrolimus in stable renal transplant recipients Transplantation 77 2004 1199 1202
46. S. Friemann, K. Stopp, B. Christ, R. Weimer, W. Padberg, W. Ernst Conversion to tacrolimus in hyperlipidemic patients Transplant Proc 31 suppl 7A 1999 S41 S43
47. T.R. McCune, L.R. Thacker II, T.G. Peters Effects of tacrolimus on hyperlipidemia after successful renal transplantation A Southeastern Organ Procurement Foundation Multicenter Clinical Study Transplantation 65 1998 87 92
48. N.B. Bouchta, L. Ghisdal, D. Abramowicz Conversion from tacrolimus to cyclosporin is associated with a significant improvement of glucose metabolism in patients with new-onset diabetes mellitus after renal transplantation Transplant Proc 37 2005 1857 1860
49. J. Oberholzer, J. Thielke, B. Hatipoglu, G. Testa, H.N. Sankary, E. Benedetti Immediate conversion from tacrolimus to cyclosporine in the treatment of posttransplantation diabetes mellitus Transplant Proc 37 2005 999 1000
50. C. Blume, M. Hollenbeck, K. Ivens, P. Heering, G.R. Hetzel, B. Grabensee Conversion from cyclosporine to tacrolimus prevents transplant function loss due to acute steroid-resistant or chronic rejection in renal allograft recipients Transplant Proc 33 2001 3161 3163
51. R. Pretagostini, M. Rossi, M. Colonnello Conversion from cyclosporin to tacrolimus in chronic allograft nephropathy Transplant Proc 33 2001 1025 1026
52. G.J. Morris-Stiff, K. Baboolal, F. Dunstan, W.A. Jurewicz Conversion from cyclosporin (Neoral®) to tacrolimus (Prograf®) in renal allograft recipients with chronic graft nephropathy Results of an observational study Transpl Int 12 1999 288 292
53. D. Cantarovich, M. Renou, A. Megnigbeto Switching from cyclosporine to tacrolimus in patients with chronic transplant dysfunction or cyclosporine-induced adverse events Transplantation 79 2005 72 78
54. P. Schnuelle, J.H. van der Heide, A. Tegzess Open randomized trial comparing early withdrawal of either cyclosporine or mycophenolate mofetil in stable renal transplant recipients initially treated with a triple drug regimen J Am Soc Nephrol 13 2002 536 543
55. P.J.H. Smak Gregoor, R.G.L. De Sévaux, G. Ligtenberg Withdrawal of cyclosporine or prednisone six months after kidney transplantation in patients on triple drug therapy A randomized, prospective, multicenter study J Am Soc Nephrol 13 2002 1365 1373
56. T.P. Theruvath, S.L. Saidman, S. Mauiyyedi Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection Transplantation 72 2001 77 83
57. P.I. Terasaki, M. Ozawa Predicting kidney graft failure by HLA antibodies A prospective trial Am J Transplant 4 2004 438 443
58. J.M. Urbizu, S. Zárraga, P. Gómez-Ullate Safety and efficacy of tacrolimus rescue therapy in 55 kidney transplant patients treated with cyclosporine Transplant Proc 35 2003 1704 1705
59. M. Thorp, A. DeMattos, W. Bennett, J. Barry, D. Norman The effect of conversion from cyclosporine to tacrolimus on gingival hyperplasia, hirsutism and cholesterol Transplantation 69 2000 1218 1224
60. M. Kohnle, P. Lütkes, U. Zimmermann, Th Philipp, U. Heemann Conversion from cyclosporine to tacrolimus in renal transplant recipients with gum hyperplasia Transplant Proc 31 suppl 7A 1999 S44 S45
61. L. Burrows, R. Knight, Y. Genyk, B. Schwartz, V. Moran, R. Anand Conversion to tacrolimus to ameliorate cyclosporine toxicity in kidney recipients Transplant Proc 30 1998 2030 2032
62. S. Busque, P. Demers, G. St-Louis Conversion from Neoral (cyclosporine) to tacrolimus of kidney transplant recipients for gingival hyperplasia or hypertrichosis Transplant Proc 30 1998 1247 1248
63. A. Tarantino, G. Montagnino, C. Ponticelli Corticosteroids in kidney transplant recipients Safety issues and timing of discontinuation Drug Saf 13 1995 145 156
64. N.R.S. Sinclair Canadian Multicentre Transplant Study Group Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts CMAJ 147 1992 645 657
65. D.E. Hricik, M.A. O'Toole, J.A. Schulak, J. Herson Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients A meta-analysis J Am Soc Nephrol 4 1993 1300 1305
66. B.L. Kasiske, H.A. Chakkera, T.A. Louis, J.Z. Ma A meta-analysis of immunosuppression withdrawal trials in renal transplantation J Am Soc Nephrol 11 2000 1910 1917
67. J. Pascual, C. Quereda, J. Zamora, D. Hernández Spanish Group for Evidence-Based Medicine in Renal Transplantation Corticosteroid withdrawal in renal transplant patients on triple therapy with a calcineurin inhibitor and mycophenolate mofetil A meta-analysis of randomized, controlled trials Transplantation 78 2004 1548 1556
68. D.E. Hricik, C.C. Whalen, J. Lautman Withdrawal of steroids after renal transplantation - Clinical predictors of outcome Transplantation 53 1992 41 45
69. N. Ahsan, D. Hricik, A. Matas Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil - A prospective randomized study Transplantation 68 1999 1865 1874
70. J.M. Grinyó, J.M. Cruzado Steroid or calcineurin inhibitor-sparing immunosuppressive protocols C. Ronco S. Chiaramonte G. Remuzzi Kidney Transplantation: Strategies to Prevent Organ Rejection. Contrib Nephrol 2005 Karger Basel, Switzerland 30 42
71. F. Vincenti Is complete avoidance of calcineurin inhibitors or steroids now possible? Importance of patient selection and choice of regimen Transplant Proc 33 suppl 4A 2001 S11 S18
72. Y. Vanrenterghem, Y. Lebranchu, R. Hené, F. Oppenheimer, H. Ekberg Steroid Dosing Study Group Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection Transplantation 70 2000 1352 1359
73. I. Rama, J.M. Cruzado, S. Gil-Vernet Steroids can be safely withdrawn from cyclosporine and mycophenolate mofetil-treated renal allograft recipients Long-term results Transplantation 80 2005 164 168
74. B.A. Julian, D.A. Laskow, J. Dubovsky, E.V. Dubovsky, J.J. Curtis, L.D. Quarles Rapid loss of vertebral mineral density after renal transplantation N Engl J Med 325 1991 544 550
75. Y. Vanrenterghem, J.-P. van Hooff, J.P. Squifflet European Tacrolimus/MMF Renal Transplantation Study Group Minimization of immunosuppressive therapy after renal transplantation Results of a randomized controlled trial Am J Transplant 5 2005 87 95
76. E. Sola, M.J. Alférez, M. Cabello, D. Burgos, M. González Molina Low-dose and rapid steroid withdrawal in renal transplant patients treated with tacrolimus and mycophenolate mofetil Transplant Proc 34 2002 1689 1690
77. R. Borrows, M. Loucaidou, J. van Tromp Steroid sparing with tacrolimus and mycophenolate mofetil in renal transplantation Am J Transplant 4 2004 1845 1851
78. R.E. Boardman, R.R. Alloway, J.W. Alexander African-American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppression Am J Transplant 5 2005 356 365
79. D.E. Hricik, T.C. Knauss, K.A. Bodziak Withdrawal of steroid therapy in African American kidney transplant recipients receiving sirolimus and tacrolimus Transplantation 76 2003 938 942
80. J.M.M. Boots, E.M. van Duijnhoven, M.H.L. Christiaans, B.H.R. Wolffenbuttel, J.P. van Hooff Glucose metabolism in renal transplant recipients on tacrolimus The effect of steroid withdrawal and tacrolimus trough level reduction J Am Soc Nephrol 13 2002 221 227
81. J.P. van Hooff, M.H.L. Christiaans, E.M. van Duijnhoven Evaluating mechanisms of post-transplant diabetes mellitus Nephrol Dial Transplant 19 suppl 6 2004 Svi8 Svi12
82. C.G. ter Meulen, I. van Riemsdijk, R.J. Hené Steroid-withdrawal at 3 days after renal transplantation with anti-IL-2 receptor α therapy A prospective, randomized, multicenter study Am J Transplant 4 2004 803 810
83. E.S. Woodle Fujisawa Corticosteroid Withdrawal Study Group A prospective, randomized, multicenter, double-blind study of early corticosteroid cessation versus long-term maintenance of corticosteroid therapy with tacrolimus and mycophenolate mofetil in primary renal transplant recipients One year report Transplant Proc 37 2005 804 808
84. R.L. Heilman, M.J. Mazur, K.S. Reddy, A. Moss, D. Post, D. Mulligan Steroid avoidance immunosuppression in low-risk kidney transplant recipients Transplant Proc 37 2005 1785 1788
85. N.R. Parrott, A.Q. Hammad, C.J.E. Watson, J.P.A. Lodge, C.D. Andrews Multicenter, randomized study of the effectiveness of basiliximab in avoiding addition of steroids to cyclosporine A monotherapy in renal transplant recipients Transplantation 79 2005 344 348
86. F. Vincenti, A. Monaco, J. Grinyo, M. Kinkhabwala, A. Roza Multicenter randomized prospective trial of steroid withdrawal in renal transplant recipients receiving basiliximab, cyclosporine microemulsion and mycophenolate mofetil Am J Transplant 3 2003 306 311
87. A.J. Matas, T. Ramcharan, S. Paraskevas Rapid discontinuation of steroids in living donor kidney transplantation A pilot study Am J Transplant 1 2001 278 283
88. K. Khwaja, M. Asolati, J. Harmon Outcome at 3 years with a prednisone-free maintenance regimen A single-center experience with 349 kidney transplant recipients Am J Transplant 4 2004 980 987
89. E.S. Woodle, F. Vincenti, M.I. Lorber A multicenter pilot study of early (4-day) steroid cessation in renal transplant recipients under Simulect, tacrolimus and sirolimus Am J Transplant 5 2005 157 166
90. S.A. Birkeland Steroid-free immunosuppression after kidney transplantation with antithymocyte globulin induction and cyclosporine and mycophenolate mofetil maintenance therapy Transplantation 66 1998 1207 1210
91. E. Cole, D. Landsberg, D. Russell A pilot study of steroid-free immunosuppression in the prevention of acute rejection in renal allograft recipients Transplantation 72 2001 845 850
92. L. Rostaing, D. Cantarovich, G. Mourad CARMEN Study Group Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation Transplantation 79 2005 807 814
93. B.D. Myers, J. Ross, L. Newton, J. Luetscher, M. Perlroth Cyclosporine-associated chronic nephropathy N Engl J Med 311 1984 699 705
94. W. Wong, J.-P. Venetz, N. Tolkoff-Rubin, M. Pascual 2005 Immunosuppressive strategies in kidney transplantation Which role for the calcineurin inhibitors? Transplantation 80 2005 289 296
95. M. Hueso, J. Bover, D. Serón Low-dose cyclosporine and mycophenolate mofetil in renal allograft recipients with suboptimal renal function Transplantation 66 1998 1727 1731
96. M.R. Weir, L. Anderson, J.C. Fink A novel approach to the treatment of chronic allograft nephropathy Transplantation 64 1997 1706 1710
97. M. Pascual, J. Curtis, F.L. Delmonico A prospective, randomized clinical trial of cyclosporine reduction in stable patients greater than 12 months after renal transplantation Transplantation 75 2003 1501 1505
98. I. Houde, P. Isenring, D. Boucher, R. Noël, J.-G. Lachanche Mycophenolate mofetil, an alternative to cyclosporine A for long-term immunosuppression in kidney transplantation? Transplantation 70 2000 1251 1253
99. D. Abramowicz, D. Manas, M. Lao Cyclosporine Withdrawal Study Group Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen in stable kidney transplant recipients A randomized, controlled study Transplantation 74 2002 1725 1734
100. P.J.H. Smak Gregoor, T. van Gelder, N.M. van Besouw, B.J. van der Mast, J.N.M. Ijzermans, W. Weimar Randomized study on the conversion of treatment with cyclosporine to azathioprine or mycophenolate mofetil followed by dose reduction Transplantation 70 2000 143 148
101. R.W.G. Johnson, H. Kreis, R. Oberbauer, C. Brattström, K. Claesson, J. Eris Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure Transplantation 72 2001 777 786
102. H. Kreis, R. Oberbauer, J.M. Campistol Rapamune Maintenance Regimen Trial Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal J Am Soc Nephrol 15 2004 809 817
103. R. Oberbauer, G. Segoloni, J.M. Campistol Rapamune Maintenance Regimen Study Group Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation Transpl Int 18 2005 22 28
104. H. Kreis, J.-M. Cisterne, W. Land Sirolimus European Renal Transplant Study Group Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients Transplantation 69 2000 1252 1260
105. C.G. Groth, L. Bäckman, J.-M. Morales Sirolimus European Renal Transplant Study Group Sirolimus (rapamycin)-based therapy in human renal transplantation Transplantation 67 1999 1036 1042
106. F. Vincenti, E. Ramos, C. Brattstrom Multicenter trial exploring calcineurin inhibitor avoidance in renal transplantation Transplantation 71 2001 1282 1287
107. H.T.B. Tran, M.K. Acharya, D.B. McKay Avoidance of cyclosporine in renal transplantation Effects of daclizumab, mycophenolate mofetil, and steroids J Am Soc Nephrol 1 2000 1903 1909
108. J.M. Grinyó, S. Gil-Vernet, J.M. Cruzado Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation Results after 5 years Transpl Int 16 2003 820 827
109. S.M. Flechner, D. Goldfarb, C. Modlin Kidney transplantation without calcineurin inhibitor drugs A prospective, randomized trial of sirolimus versus cyclosporine Transplantation 74 2002 1070 1076
110. S.J. Knechtle, J.D. Pirsch, J.H. Fechner Jr Campath-1H induction plus rapamycin monotherapy for renal transplantation Results of a pilot study Am J Transplant 3 2003 722 730
111. J. Cai, P.I. Terasaki, D.D. Bloom Correlation between human leukocyte antigen antibody production and serum creatinine in patients receiving sirolimus monotherapy after Campath-1H induction Transplantation 78 2004 919 924
112. F. Vincenti, C. Larsen, A. Durrbach Belata Study Group Costimulation blockade with belatacept in renal transplantation N Engl J Med 353 2005 770 781